Clinical trials
Completed Alzheimer Disease trials in Argentina
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2021 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| H. Lundbeck A/S | 3 |
| Hoffmann-La Roche | 3 |
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| Alector Inc. | 1 |
| Axovant Sciences Ltd. | 1 |
| Forest Laboratories | 1 |
| Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 22 |
| Amyloid Neuropathies, Familial | 3 |
| Amyloidosis | 3 |
| Dementia | 2 |
| Polyneuropathies | 2 |
| Brain Diseases | 1 |
| Cognitive Dysfunction | 1 |
| Memory Disorders | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.